Junko Tamaki

Junko Tamaki

Auto-generated profile, based on publicly available information

Junko Tamaki

Department of Hygiene and Public Health, Faculty of Medicine, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
JKJ.A. Kanis
J.A. Kanis
HJH. Johansson
H. Johansson
EME.V. McCloskey
E.V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
KÅKRISTINA E ÅKESSON
KRISTINA E ÅKESSON
WLW.D. Leslie
W.D. Leslie

31 May 2022 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LVL. Vandenput
L. Vandenput
HJH. Johansson
H. Johansson
EME. V. McCloskey
E. V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
KÅKRISTINA E ÅKESSON
KRISTINA E ÅKESSON
JKJ. A. Kanis
J. A. Kanis

16 January 2019 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
FFfor the Working Group of Japan Osteoporosis Foundation
for the Working Group of Japan Osteoporosis Foundation
JTJ. Tamaki
J. Tamaki
KFK. Fujimori
K. Fujimori
SIS. Ikehara
S. Ikehara
KKK. Kamiya
K. Kamiya
MIM. Iki
M. Iki

17 January 2024 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LVLiesbeth Vandenput
Liesbeth Vandenput
HJHelena Johansson
Helena Johansson
EMEugene V. McCloskey
Eugene V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
Marian SchiniMarian Schini
Marian Schini
JKJohn A. Kanis
John A. Kanis

27 February 2017 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
FGfor the JPOS Study Group
for the JPOS Study Group
JTJ. Tamaki
J. Tamaki
MIM. Iki
M. Iki
YSY. Sato
Y. Sato
EKE. Kajita
E. Kajita
SKS. Kagamimori
S. Kagamimori

8 August 2025 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
NHNicholas C Harvey
Nicholas C Harvey
HJHelena Johansson
Helena Johansson
EMEugene V McCloskey
Eugene V McCloskey
Enwu LiuEnwu Liu
Enwu Liu
KÅKRISTINA E ÅKESSON
KRISTINA E ÅKESSON
JKJohn A Kanis
John A Kanis
The aim of this international meta-analysis was to quantify the predictive value of BMI for incident fracture and relationship of this risk with age, sex, follow-up time, and BMD. A total of 1 667 922 men and women from 32 countries (63 cohorts), followed for a total of 16.0 million person-years were studied. 293 325 had FN BMD measured (2.2 million person-years follow-up). An extended Poisson model in each cohort was used to investigate relationships between WHO-defined BMI categories (Underweight: <18.5 kg/m2; Normal: 18.5-24.9 kg/m2; Overweight: 25.0-29.9 kg/m2; Obese I: 30.0-34.9 kg/m2; Obese II: ≥35.0 kg/m2) and risk of incident osteoporotic, major osteoporotic and hip fracture (HF). Inverse-variance weighted β-coefficients were used to merge the cohort-specific results. For the subset with BMD available, in models adjusted for age and follow-up time, the hazard ratio (95% CI) for HF comparing underweight with normal weight was 2.35 (2.10-2.60) in women and for men was 2.45 (1.90-3.17). Hip fracture risk was lower in overweight and obese categories compared to normal weight [obese II vs normal: women 0.66 (0.55-0.80); men 0.91 (0.66-1.26)]. Further adjustment for FN BMD T-score attenuated the increased risk associated with underweight [underweight vs normal: women 1.69 (1.47-1.96); men 1.46 (1.00-2.13)]. In these models, the protective effects of overweight and obesity were attenuated, and in both sexes, the direction of association reversed to higher fracture risk in Obese II category [Obese II vs Normal: women 1.24 (0.97-1.58); men 1.70 (1.06-2.75)]. Results were similar for other fracture outcomes. Underweight is a risk factor for fracture in both men and women regardless of adjustment for BMD. However, while overweight/obesity appeared protective in base models, they became risk factors after additional adjustment for FN BMD, particularly in the Obese II category. This effect in the highest BMI categories was of greater magnitude in men than women. These results will inform the second iteration of FRAX®.